CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $1.35 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $1.35M, a 68.79% increase from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $801.00K, a 80.26% decline from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $4.06M, a 185.77% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $1.42M, a 6.77% increase from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month as first filed |
|---|---|---|
| 2025-12-27 | $1.35M 10-K · filed 2026-02-18 | |
| 2024-12-28 | $801.00K 10-K · filed 2026-02-18 | |
| 2023-12-30 | $4.06M 10-K · filed 2026-02-18 | |
| 2022-12-31 | $1.42M 10-K · filed 2025-02-19 | |
| 2021-12-25 | $1.33M 10-K · filed 2024-02-14 | |
| 2020-12-26 | $127.00K 10-K · filed 2023-02-22 | |
| 2019-12-28 | $1.03M 10-K · filed 2022-02-16 | |
| 2018-12-29 | $4.54M 10-K · filed 2021-02-17 | |
| 2017-12-30 | $0.00 10-K · filed 2020-02-11 | |
| 2016-12-31 | $1.87M 10-K · filed 2019-02-13 | |
| 2015-12-26 | $3.99M 10-K · filed 2018-02-13 | |
| 2014-12-27 | $3.72M 10-K · filed 2017-02-14 | -$3.72M 10-K · filed 2015-02-17 |
| 2013-12-28 | $732.00K 10-K · filed 2016-02-12 | |
| 2012-12-29 | $28.00K 10-K · filed 2015-02-17 | |
| 2011-12-31 | $239.00K 10-K · filed 2014-02-25 | |
| 2010-12-25 | $1.80M 10-K · filed 2013-02-27 | |
| 2009-12-26 | $1.02M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |